<DOC>
	<DOCNO>NCT00373685</DOCNO>
	<brief_summary>This study investigate Celebrex low incident Gastrointestinal Events NSAIDS subject osteoarthritis .</brief_summary>
	<brief_title>GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs ( NSAIDS )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Male female patient least 55 year age clinical diagnosis OA expect require daily prescription antiinflammatory analgesic therapy arthritis symptom management either celecoxib nsNSAID appropriate treatment option . GI ulcer hemorrhage active GD ulceration le 90 day prior screen visit . Patients history myocardial infarction , unstable angina , ischemic hemorrhagic stroke , transient ischemic attack , previous revascularization procedure coronary , carotid , cerebral , renal , aortic peripheral arterial vasculature .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>GI event patient moderate GI risk treat NSAIDS</keyword>
</DOC>